$12.39B
Revenue
$832.50M
Net Income
12.06%
Gross Margin
8.40%
Op. Margin
$421.60M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Total Revenue | $12.39B | $12.39B | $9.65B |
| Revenue Growth % | 0.0% | 28.5% | nan% |
| Cost of Revenue | $10.90B | $10.90B | $8.61B |
| Gross Profit | $1.49B | $1.49B | $1.03B |
| Gross Margin % | 12.1% | 12.1% | 10.7% |
| Research & Development | $118.20M | $118.20M | $78.00M |
| Selling General & Admin | $259.90M | $259.90M | $293.50M |
| Operating Income | $1.04B | $1.04B | $599.30M |
| Operating Margin % | 8.4% | 8.4% | 6.2% |
| Interest Expense | $54.10M | $54.10M | $52.90M |
| Other Income/Expense | $-4.90M | $-4.90M | $-15.00M |
| Income Before Tax | $983.20M | $983.20M | $532.20M |
| Income Tax Expense | $150.70M | $150.70M | $104.20M |
| Net Income | $832.50M | $832.50M | $428.00M |
| Net Margin % | 6.7% | 6.7% | 4.4% |
| Basic EPS | nan | 7.22 | 3.62 |
| Diluted EPS | nan | 7.16 | 3.61 |
| Basic Shares Outstanding | -100K | 115.3M | 118.1M |
| Diluted Shares Outstanding | - | 116.2M | 118.7M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|
| Cash & Cash Equivalents | $595.60M | $423.30M |
| Inventory | $2.19B | $1.76B |
| Other Current Assets | $251.50M | $250.80M |
| Total Current Assets | $5.67B | $4.51B |
| Goodwill | $333.10M | $340.50M |
| Intangible Assets | $266.20M | $308.00M |
| Other Non-current Assets | $74.10M | $78.20M |
| Total Assets | $7.21B | $5.99B |
| Accounts Payable | $1.87B | $1.29B |
| Deferred Revenue | $407.10M | $511.60M |
| Total Current Liabilities | $3.94B | $3.02B |
| Long-term Debt | $750.50M | $770.20M |
| Deferred Tax Liabilities | $41.20M | $49.40M |
| Total Liabilities | $5.00B | $4.09B |
| Common Stock | $1.62B | $1.63B |
| Retained Earnings | $408.70M | $-423.80M |
| Total Stockholders Equity | $2.22B | $1.90B |
| Total Liabilities & Equity | $7.21B | $5.99B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Net Income | $918.70M | $832.50M | $428.00M |
| Depreciation & Amortization | $213.10M | $175.70M | $151.90M |
| Stock-based Compensation | $69.80M | $69.80M | $57.40M |
| Deferred Income Tax | $-68.50M | $-68.40M | $-31.90M |
| Change in Receivables | $636.00M | $569.10M | $270.70M |
| Change in Inventory | $427.40M | $427.40M | $-343.70M |
| Operating Cash Flow | $659.50M | $659.50M | $473.90M |
| Capital Expenditure | $237.90M | $201.20M | $170.90M |
| Acquisitions | - | - | $36.10M |
| Investing Cash Flow | $-240.40M | $-203.70M | $-212.50M |
| Stock Issued | $300.00K | $300.00K | $3.90M |
| Stock Repurchased | $231.10M | $153.40M | $152.00M |
| Financing Cash Flow | $-497.40M | $-283.50M | $-208.50M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $3.19B | - | $8.74B | - |
| Cost of Revenue | $2.78B | - | $7.67B | - |
| Gross Profit | $416.10M | - | $1.06B | - |
| Research & Development | $36.40M | - | $88.00M | - |
| Selling General & Admin | $38.40M | - | $189.80M | - |
| Operating Income | $325.00M | - | $726.30M | - |
| Interest Expense | $13.40M | - | $40.70M | - |
| Other Income/Expense | $-1.30M | - | $-4.40M | - |
| Income Before Tax | $310.90M | - | $681.90M | - |
| Income Tax Expense | $43.10M | - | $116.90M | - |
| Net Income | $267.80M | - | $565.00M | - |
| Basic EPS | 2.33 | - | 4.90 | - |
| Diluted EPS | 2.31 | - | 4.86 | - |
| Basic Shares Outstanding | $115.00M | - | $115.40M | - |
| Diluted Shares Outstanding | $115.90M | - | $116.20M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $305.90M | $423.30M |
| Inventory | $2.05B | $1.76B |
| Other Current Assets | $350.90M | $259.30M |
| Total Current Assets | $5.14B | $4.51B |
| Goodwill | $340.70M | $340.50M |
| Intangible Assets | $275.40M | $308.00M |
| Other Non-current Assets | $71.90M | $78.20M |
| Total Assets | $6.61B | $5.99B |
| Accounts Payable | $1.68B | $1.29B |
| Total Current Liabilities | $3.50B | $3.02B |
| Long-term Debt | $756.70M | $770.20M |
| Deferred Tax Liabilities | $45.10M | $49.40M |
| Other Non-current Liabilities | $179.90M | $167.40M |
| Total Liabilities | $4.58B | $4.09B |
| Total Stockholders Equity | $2.03B | $1.90B |
| Total Liabilities & Equity | $6.61B | $5.99B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $267.80M | - | $565.00M | - |
| Depreciation & Amortization | $40.30M | - | $123.00M | - |
| Stock-based Compensation | $15.60M | - | $56.80M | - |
| Deferred Income Tax | $-1.10M | - | $-16.10M | - |
| Change in Receivables | $151.50M | - | $370.30M | - |
| Change in Inventory | $128.60M | - | $286.10M | - |
| Operating Cash Flow | $126.20M | - | $408.90M | - |
| Capital Expenditure | $37.30M | - | $106.50M | - |
| Acquisitions | - | - | - | - |
| Investing Cash Flow | $-37.30M | - | $-109.00M | - |
| Stock Issued | - | - | $300.00K | - |
| Stock Repurchased | - | - | $117.70M | - |
| Financing Cash Flow | $-96.80M | - | $-417.30M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.